Taylor Andrew Lawrence's Form 4 filing
Orchestra BioMed Holdings, Inc. (OBIO) · filed Aug 28, 2026
- Accession no.
- 0001104659-26-103210
- Filed
- Aug 28, 2026, 4:16 PM ET
- Trade date
- Aug 26, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Taylor Andrew LawrenceCIK 0001723889 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock, par value $0.0001 per share | FTax withholdingDisposed | −3,076 | $5.26 | −$16,179.76 | 589,989 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.